| Montelukast vs. inhaled low-dose budesonide as monotherapy in the treatment of mild persistent asthma: a randomized double blind controlled trial. | |
| | |
MedLine Citation:
|
PMID: 17623754 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND: Guidelines recommend daily controller therapy for mild persistent asthma. Montelukast has demonstrated consistent benefit in controlling symptoms of asthma and may be an alternative, orally administered, nonsteroidal agent for treating mild asthma. Aim: To determine whether montelukast is as effective as budesonide in controlling mild persistent asthma as determined by FEV(1). METHODS: Between November 2003 to October 2005, participants aged 5-15 years with recently diagnosed mild persistent asthma (n = 62) were randomized to oral montelukast (5 mg daily) [N(1) = 30] or inhaled budesonide (400 microg per day in two doses) [N(2) = 32] in a single center, double-blind study. RESULTS: Baseline demographic and spirometric parameters were comparable. The median (95% confidence interval) percentage predicted FEV(1) was similar in the two groups after 12 weeks of treatment (budesonide: 76.70 (67.96-90.53%), montelukast: 75 (67.40-88.47)%; p = 0.44). There was similar improvement in spirometric parameters and clinical symptom scores in both the groups. There was no statistically significant difference between the groups in the need for rescue drugs as well as side effects reported by parents. CONCLUSION: Montelukast is as effective as inhaled budesonide in the treatment of mild persistent asthma in children aged 5-15 years. Montelukast may be used as an alternative to low dose inhaled corticosteroids for management of mild persistent asthma. |
| | |
Authors:
|
Vikram Kumar; P Ramesh; Rakesh Lodha; R M Pandey; S K Kabra |
Related Documents
:
|
15813664 - Comparison of the bronchodilating effects of formoterol and albuterol delivered by hydr... 16308544 - Plant-based formulation for bronchial asthma: a controlled clinical trial to compare it... 18939724 - The relationship between asthma control and quality-of-life impairment due to chronic c... 15764724 - Comparison of inhaled fluticasone with intravenous hydrocortisone in the treatment of a... 15381444 - Understanding the pattern of ptsd symptomatology: a comparison of between versus within... 22140424 - Establishing long-term efficacy in chronic disease: use of recursive partitioning and p... |
Publication Detail:
|
Type: Comparative Study; Journal Article; Randomized Controlled Trial Date: 2007-07-10 |
Journal Detail:
|
Title: Journal of tropical pediatrics Volume: 53 ISSN: 0142-6338 ISO Abbreviation: J. Trop. Pediatr. Publication Date: 2007 Oct |
Date Detail:
|
Created Date: 2007-11-06 Completed Date: 2008-03-19 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8010948 Medline TA: J Trop Pediatr Country: England |
Other Details:
|
Languages: eng Pagination: 325-30 Citation Subset: IM |
Affiliation:
|
Department of Pediatrics, AIIMS, Ansari Nagar, New Delhi 110029, India. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Acetates
/
pharmacology,
therapeutic use* Administration, Inhalation Adolescent Anti-Asthmatic Agents / administration & dosage, pharmacology, therapeutic use* Anti-Inflammatory Agents / administration & dosage, pharmacology, therapeutic use* Asthma / drug therapy* Budesonide / administration & dosage, pharmacology, therapeutic use* Child Child, Preschool Chronic Disease Double-Blind Method Female Forced Expiratory Volume / drug effects Humans India Male Quinolines / pharmacology, therapeutic use* |
| Chemical | |
Reg. No./Substance:
|
0/Acetates; 0/Anti-Asthmatic Agents; 0/Anti-Inflammatory Agents; 0/Quinolines; 158966-92-8/montelukast; 51333-22-3/Budesonide |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Substantial working muscle glycerol turnover during two-legged cycle ergometry.
Next Document: Lactation safety recommendations and reliability compared in 10 medication resources.